Fig. 3

Correlations between two common GTs and immune infiltration, immunomodulators, immune checkpoints, and immunotherapy. A, B Relationships between ALG3 (A), POMT2 (B) expression and the abundance of 22 immune cell types, analyzed using Pearson correlation analysis. C Correlation between ALG3 or POMT2 expression and 59 immunomodulators. D, E Associations between ALG3 (D) and POMT2 (E) expression and 46 immune checkpoints, evaluating using Pearson correlation analysis. F, G Responsiveness of patients with low- or high-ALG3 (F) or POMT2 (G) expression to immunotherapy, including anti-CTLA-4 and anti-PD1 treatment. *P < 0.05, **P < 0.01, ***P < 0.001